Clinical and Immunohisochemical Evaluation of Chemopreventive Effect of Thymoquinone on Oral Potentially Malignant Lesions.

NCT03208790 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Premalignant Lesion

Interventions

DRUG: Nigella sativa buccal tablets 10mg
DRUG: Nigella sativa buccal tablets 5mg
DRUG: Placebo buccal tablets

Sponsor

Cairo University